Depression News and Research

Latest Depression News and Research

Galapagos honored with 2010 EUROPEAN BIOTECHNICA AWARD

The Belgian biotech company Galapagos has won the 2010 EUROPEAN BIOTECHNICA AWARD. Galapagos thus secures the lion's share of the prize money totalling 75,000 euros, which is offered every year in the competition staged by Deutsche Messe AG and its partners. The award celebrates innovative European companies from the biotechnology sector and the life sciences.

5 Oct 2010

Supplemental brief dynamic therapy does not benefit patients with obsessive-compulsive disorder: Study

This study demonstrates that supplemental brief dynamic therapy in the treatment of patients with obsessive compulsive-disorder with concurrent major depressive disorder (who are receiving effective medication) has no significant clinical effect on both obsessive and depressive symptoms.

5 Oct 2010

GPs less successful in identifying depression in older people

Depression in the elderly is frequently unrecognized by physicians. This study attempts to understand why. Studies that examined the unassisted (clinical) ability of general practitioners (GPs; primary care physicians) to identify depression were divided into those of older adults, younger adults and mixed populations.

5 Oct 2010

International conference on brain stimulation in psychiatry and neurology to be held October 7 and 8

Thirteen national and international experts in the field of Brain Stimulation in Psychiatry and Neurology will meet October 7 and 8 during a conference held at the Douglas Mental Health University Institute. They will present research findings and ground-breaking clinical applications concerning the use of brain stimulation techniques. New treatments still under development, such as transcranial magnetic stimulation, will also be discussed. Close to 150 participants are expected to take part in this conference.

5 Oct 2010

Nursing staff have 'difficulty' detecting depression and distress in patients: Study

New research from the University of Leicester reveals that nursing staff have 'considerable difficulty' detecting depression and distress in patients.

5 Oct 2010

Researchers complete first studies of mephedrone drug ban in Northern Ireland

Researchers at Queen's University Belfast have completed one of the first studies of mephedrone use in Northern Ireland since the drug was outlawed earlier this year. They found that the ban did not deter those mephedrone users surveyed from taking the substance.

5 Oct 2010

Study: 18% of children with ADHD suffered from depression as adolescents

Children diagnosed with attention deficit/hyperactivity disorder (ADHD) at ages 4 to 6 are more likely to suffer from depression as adolescents than those who did not have ADHD at that age, according to a long-term study published in the October issue of the Archives of General Psychiatry. Although it was an uncommon occurrence, the children with ADHD also were somewhat more likely to think about or attempt suicide as adolescents.

5 Oct 2010

Study finds children with ADHD have high risk for adolescent depression

Young children with attention-deficit/hyperactivity disorder (ADHD) appear to be at greater risk for adolescent depression and/or suicide attempts five to 13 years after diagnosis, according to a report in the October issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

5 Oct 2010

Evotec enters multiple target drug discovery collaboration with Shionogi

Evotec AG today announced that it has entered into a multiple target drug discovery collaboration with Shionogi & Co Ltd., to identify small molecule modulators of various protein-protein interaction targets.

5 Oct 2010

Depressed pregnant women at increased risk of delivering preterm birth and low-birth weight infants

Clinical depression puts pregnant women at increased risk of delivering prematurely and of giving birth to below-normal weight infants, according to a report published Oct. 4 in the Archives of General Psychiatry.

5 Oct 2010

Neuro-Biotech introduces biomarker for progressive clinical investigation on Alzheimer's Disease

Neuro-Biotech Corporation introduces a Neuro-biomarker which is linked to a series of Neuro-Bio tests. This will permit to understand the science behind them and how they each will contribute to a progressive clinical investigation involving the input and output of the brain.

5 Oct 2010

Reduced levels of brain-derived neurotrophic factor are a trait marker for psychogenic non-epileptic seizures

New research from Rhode Island Hospital found that reduced levels of brain-derived neurotrophic factor (BDNF), a protein in the brain that encourages growth of neurons, may be a trait marker for individuals with psychogenic non-epileptic seizures (PNES) (seizures that are psychological in origin). The findings are published in the October 4, 2010, issue of Neurology, the medical journal of the American Academy of Neurology.

5 Oct 2010

Depression treatment guidelines updated

There has been an update in the treatment of clinical depression. This includes suggestions on the use of medication, talk therapy, exercise, and alternative treatments and puts more emphasis on tailor made treatments for patients.

4 Oct 2010

Healthcare system does not take girls with autism or ADHD symptoms seriously

When girls with symptoms of autism or ADHD seek professional medical help, their problems are often played down or misinterpreted, and there is a real risk that they will not get the help or support they need. As such, more training is needed in this area, particularly in the public sector, reveals a thesis from the University of Gothenburg.

4 Oct 2010

J&JPRD receives FDA Complete Response Letter for tapentadol ER tablets NDA

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) announced today that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for tapentadol extended release tablets.

4 Oct 2010

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Merck today announced that final results from two pivotal Phase III studies of boceprevir, its investigational oral hepatitis C protease inhibitor, will be presented in oral plenary sessions at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), which is taking place from Oct. 29 through Nov. 2 in Boston. Results for boceprevir in response-guided therapy strategies, which evaluated treatment durations shorter than current standard therapy, will be presented during the meeting.

4 Oct 2010

Mind-body intervention effective in treating persistent fatigue in breast cancer survivors

A group-based, holistic, mind-body intervention was equally effective in treating persistent fatigue and improving quality of life for breast cancer survivors, regardless of their race.

4 Oct 2010

New SymPath kit measures DBH activity of Sympathetic Nervous System

Biotech Corporation in acquiring licenses to commercialize 12 Neuro-biomarkers has first focused on SymPath(R) and is now ready to give you the opportunity to shed some light about this Neuro-biomarker of the Sympathetic Nervous System (SNS). Here is a peak into the research behind the Neuro-blood testing that will be available to all patients through their health system.

4 Oct 2010

Telemedicine can help address mental health needs of elderly homebound individuals

Studies have shown a high rate of depression among elderly homebound individuals, and few patients receive adequate treatment, if any. To address this issue, researchers at Rhode Island Hospital and other organizations have developed a telemedicine-based depression care protocol in home health care.

4 Oct 2010

Scientists find several common findings on diabetes management

Diabetes is on the rise. The seventh leading cause of death in the U.S. today, it affects 24 million people, nearly 3 times the number in 1980. Another 57 million have a condition that puts them at heightened risk of the illness.

3 Oct 2010

Depression News and Research

Latest Depression News and Research

Galapagos honored with 2010 EUROPEAN BIOTECHNICA AWARD

Supplemental brief dynamic therapy does not benefit patients with obsessive-compulsive disorder: Study

GPs less successful in identifying depression in older people

International conference on brain stimulation in psychiatry and neurology to be held October 7 and 8

Nursing staff have 'difficulty' detecting depression and distress in patients: Study

Researchers complete first studies of mephedrone drug ban in Northern Ireland

Study: 18% of children with ADHD suffered from depression as adolescents

Study finds children with ADHD have high risk for adolescent depression

Evotec enters multiple target drug discovery collaboration with Shionogi

Depressed pregnant women at increased risk of delivering preterm birth and low-birth weight infants

Neuro-Biotech introduces biomarker for progressive clinical investigation on Alzheimer's Disease

Reduced levels of brain-derived neurotrophic factor are a trait marker for psychogenic non-epileptic seizures

Depression treatment guidelines updated

Healthcare system does not take girls with autism or ADHD symptoms seriously

J&JPRD receives FDA Complete Response Letter for tapentadol ER tablets NDA

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Mind-body intervention effective in treating persistent fatigue in breast cancer survivors

New SymPath kit measures DBH activity of Sympathetic Nervous System

Telemedicine can help address mental health needs of elderly homebound individuals

Scientists find several common findings on diabetes management

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Depression News and Research

Latest Depression News and Research

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in